Observe Medical ASA (OSL:OBSRV)
Norway
· Delayed Price · Currency is NOK 1.160
-0.010 (-0.85%)
At close: Apr 28, 2026
Observe Medical ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Operating Revenue | 18.81 | 17.23 | 27.94 | 19.52 | 24.04 | Upgrade
|
| Other Revenue | - | 1.26 | - | - | - | Upgrade
|
| Revenue | 18.81 | 18.48 | 27.94 | 19.52 | 24.04 | Upgrade
|
| Revenue Growth (YoY) | 1.77% | -33.85% | 43.14% | -18.80% | 711.96% | Upgrade
|
| Cost of Revenue | 14.11 | 15.41 | 18.66 | 14.34 | 14.52 | Upgrade
|
| Gross Profit | 4.7 | 3.07 | 9.29 | 5.18 | 9.52 | Upgrade
|
| Selling, General & Admin | 15.89 | 15.29 | 24.22 | 27.31 | 17.26 | Upgrade
|
| Other Operating Expenses | 12.83 | 17.81 | 28.02 | 26.08 | 20.72 | Upgrade
|
| Operating Expenses | 42.04 | 47.47 | 66.39 | 64.32 | 41.44 | Upgrade
|
| Operating Income | -37.34 | -44.4 | -57.1 | -59.14 | -31.93 | Upgrade
|
| Interest Expense | -5.17 | -9.55 | -6.65 | -3.82 | -3.33 | Upgrade
|
| Interest & Investment Income | 0 | 1.78 | 0.06 | 0.28 | - | Upgrade
|
| Currency Exchange Gain (Loss) | 3.46 | -5.42 | -4.28 | 1.64 | 4.64 | Upgrade
|
| Other Non Operating Income (Expenses) | 39.04 | -0.02 | -1.82 | 0.65 | -0.43 | Upgrade
|
| EBT Excluding Unusual Items | -0.02 | -57.61 | -69.78 | -60.39 | -31.04 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -4.62 | Upgrade
|
| Impairment of Goodwill | - | -2.68 | -67.11 | - | - | Upgrade
|
| Asset Writedown | -41.73 | - | - | - | - | Upgrade
|
| Other Unusual Items | -6.9 | 1.56 | 1.81 | 9.67 | 9.34 | Upgrade
|
| Pretax Income | -48.64 | -58.73 | -135.08 | -50.73 | -26.32 | Upgrade
|
| Income Tax Expense | - | - | 0.02 | 0.08 | - | Upgrade
|
| Net Income | -48.64 | -58.73 | -135.1 | -50.8 | -26.32 | Upgrade
|
| Net Income to Common | -48.64 | -58.73 | -135.1 | -50.8 | -26.32 | Upgrade
|
| Shares Outstanding (Basic) | 67 | 15 | 4 | 3 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 67 | 15 | 4 | 3 | 1 | Upgrade
|
| Shares Change (YoY) | 336.95% | 297.36% | 22.13% | 140.67% | 18.29% | Upgrade
|
| EPS (Basic) | -0.73 | -3.85 | -35.17 | -16.15 | -20.14 | Upgrade
|
| EPS (Diluted) | -0.73 | -3.90 | -35.17 | -16.20 | -20.14 | Upgrade
|
| Free Cash Flow | -25.97 | -29.27 | -32.47 | -52.74 | -22.34 | Upgrade
|
| Free Cash Flow Per Share | -0.39 | -1.92 | -8.45 | -16.77 | -17.09 | Upgrade
|
| Gross Margin | 24.98% | 16.63% | 33.24% | 26.52% | 39.59% | Upgrade
|
| Operating Margin | -198.51% | -240.21% | -204.36% | -302.97% | -132.79% | Upgrade
|
| Profit Margin | -258.57% | -317.74% | -483.50% | -260.24% | -109.48% | Upgrade
|
| Free Cash Flow Margin | -138.07% | -158.38% | -116.21% | -270.16% | -92.94% | Upgrade
|
| EBITDA | -26.37 | -32.56 | -46.82 | -51.61 | -31.11 | Upgrade
|
| EBITDA Margin | -140.19% | -176.18% | -167.56% | -264.36% | -129.38% | Upgrade
|
| D&A For EBITDA | 10.97 | 11.84 | 10.28 | 7.54 | 0.82 | Upgrade
|
| EBIT | -37.34 | -44.4 | -57.1 | -59.14 | -31.93 | Upgrade
|
| EBIT Margin | -198.51% | -240.21% | -204.36% | - | -132.79% | Upgrade
|
| Advertising Expenses | 0.02 | 0.14 | 0.11 | 0.3 | 0.7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.